Efficacy and safety of anakinra and canakinumab in PSTPIP1-associated inflammatory diseases: a comprehensive scoping review

Efficacy and safety of anakinra and canakinumab in PSTPIP1-associated inflammatory diseases: a comprehensive scoping review

IntroductionThis scoping review explores the effectiveness of IL-1 pathway inhibitors in managing PSTPIP1-associated inflammatory diseases (PAID). These diseases are marked by abnormal IL-1 pathway activation due to genetic mutations.MethodsOur methodology adhered to a pre-published protocol and inv...

Full description

Bibliographic Details
Main Authors:	Juan Luis Sanz-Cabanillas, Francisco Gómez-García, Pedro Jesús Gómez-Arias, Ana Montilla-López, Jesús Gay-Mimbrera, Juan Ruano, Beatriz Isla-Tejera, Esmeralda Parra-Peralbo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Immunology
Subjects:	autoinflammatory diseases PSTPIP1 gene mutations PAID interleukin 1 pathway IL-1 inhibitors anakinra
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1339337/full

Similar Items

PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome; a case presenting as a perinatal event with early central nervous system involvement?
by: Bethany Gillies Whiteside, et al.
Published: (2022-07-01)

Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA
by: Francisco Gómez-García, et al.
Published: (2018-11-01)

Schnitzler syndrome refractory to anakinra: successful treatment with canakinumab
by: Angel Luis Salcedo-Mingoarranz, et al.
Published: (2023-12-01)

Kidney Involvement in PSTPIP1 Associated Inflammatory Diseases (PAID): A Case Report and Review of the Literature
by: Paola Borgia, et al.
Published: (2021-10-01)

Rare missense variants in the SH3 domain of PSTPIP1 are associated with hidradenitis suppurativa
by: David J. Morales-Heil, et al.
Published: (2023-04-01)

<i>PSTPIP1</i>-associated incomplete PAPA syndrome. Case report
by: Dali Sh. Macharadze, et al.
Published: (2022-11-01)

A Scoping Review on Use of Drugs Targeting the JAK/STAT Pathway in Psoriasis
by: Francisco Gómez-García, et al.
Published: (2022-02-01)

Clinical and genetic characteristics of PSTPIP1-associated myeloid-related proteinemia inflammatory syndrome
by: Dan Zhang, et al.
Published: (2021-10-01)

Molecular interactions of adaptor protein PSTPIP2 control neutrophil-mediated responses leading to autoinflammation
by: Nataliia Pavliuchenko, et al.
Published: (2022-12-01)

Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
by: Ana M. Montilla, et al.
Published: (2019-10-01)

Application of anakinra in inflammatory dermatoses
by: Xiaomei YOU, et al.
Published: (2024-01-01)

Assessment of effectiveness of anakinra and canakinumab in patients with colchicine-resistant/unresponsive familial Mediterranean fever
by: Ali Şahin, et al.
Published: (2020-01-01)

Effectiveness and safety of anakinra in gouty arthritis: A case series and review of the literature
by: Sicylle Jeria-Navarro, et al.
Published: (2023-01-01)

Evolution of international collaborative research efforts to develop non-Cochrane systematic reviews.
by: Isabel Viguera-Guerra, et al.
Published: (2019-01-01)

The IL-1 Antagonist Anakinra Attenuates Glioblastoma Aggressiveness by Dampening Tumor-Associated Inflammation
by: Max Hübner, et al.
Published: (2020-02-01)

Use of Anakinra in steroid dependent recurrent pericarditis: a case report and review of literature
by: Vinay Kumar Thallapally, et al.
Published: (2021-07-01)

Use of anakinra in severe COVID-19: A case report
by: Giovanni Filocamo, et al.
Published: (2020-07-01)

PSTPIP1-Associated Myeloid-Related Proteinemia Inflammatory (PAMI) Syndrome: A Systematic Review
by: Manel Mejbri, et al.
Published: (2023-08-01)

Pyoderma gangrenosum-like necrotizing panniculitis associated with Imatinib: A case report
by: Jorge Hernández Parada, et al.
Published: (2020-07-01)

Off-Label studies on anakinra in dermatology: a review
by: Kyle Tegtmeyer, et al.
Published: (2022-01-01)

PSTPIP2 regulates synovial macrophages polarization and dynamics via ERβ in the joint microenvironment
by: Yao Yao, et al.
Published: (2022-11-01)

DNMT3a-mediated methylation of PSTPIP2 enhances inflammation in alcohol-induced liver injury via regulating STAT1 and NF-κB pathway
by: Jie-Jie Xu, et al.
Published: (2022-03-01)

An Unusual Case of Allergic Reaction to Anakinra in a Patient with Tumor Necrosis Factor Receptor-1 Associated Periodic Syndrome (TRAPS) and Subsequent Canakinumab Treatment
by: Marta Mejias Trueba, et al.
Published: (2020-07-01)

Author-paper affiliation network architecture influences the methodological quality of systematic reviews and meta-analyses of psoriasis.
by: Juan Luis Sanz-Cabanillas, et al.
Published: (2017-01-01)

Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
by: Rahul Gupta
Published: (2022-04-01)

Efficacy of Anakinra on Multiple Coronary Arteries Aneurysms in an Infant with Recurrent Kawasaki Disease, Complicated by Macrophage Activation Syndrome
by: Grazia Bossi, et al.
Published: (2022-05-01)

PSTPIP2 Inhibits the Inflammatory Response and Proliferation of Fibroblast-Like Synoviocytes in vitro
by: Yao Yao, et al.
Published: (2018-12-01)

The role of interleukin 1 in the development of human diseases: focus on Anakinra (IL-1 receptor antagonist)
by: E. L. Nasonov, et al.
Published: (2022-07-01)

Protective effect of anakinra on audiovestibular function in a murine model of endolymphatic hydrops
by: Na Zhang, et al.
Published: (2022-12-01)

Anakinra for the Treatment of Hemophagocytic Lymphohistiocytosis: 21 Cases
by: Clara Baverez, et al.
Published: (2022-09-01)

Comparison of Tocilizumab and Anakinra in the Treatment of COVID-19: A Single-Center Experience
by: Bengisu Pınar Acat, et al.
Published: (2022-08-01)

The differential impact of scientific quality, bibliometric factors, and social media activity on the influence of systematic reviews and meta-analyses about psoriasis.
by: Juan Ruano, et al.
Published: (2018-01-01)

Abstract analysis method facilitates filtering low-methodological quality and high-bias risk systematic reviews on psoriasis interventions
by: Francisco Gómez-García, et al.
Published: (2017-12-01)

Subcutaneous anakinra in the management of refractory MIS-C in France
by: Perrine Dusser, et al.
Published: (2024-02-01)

Erratum in: Budget Impact Analysis of anakinra in the treatment of patients with Still’s Disease
by: Roberto Ravasio, et al.
Published: (2020-09-01)

Evolution of appraisal tool usage preferences in PROSPERO records: a study of non-Cochrane systematic reviews
by: J. Ruano, et al.
Published: (2023-12-01)

Long-term control of refractory Schnitzler syndrome with anakinra: a case report
by: Hsien-Yi Chiu, et al.
Published: (2010-06-01)

Analysis of Anakinra Therapy for the Deficiency of Interleukin-1 Receptor Antagonist through Clinical Evidence
by: Kathryn Pillai, et al.
Published: (2024-02-01)

A child with resistant Kawasaki disease successfully treated with anakinra: a case report
by: J. Sánchez-Manubens, et al.
Published: (2017-04-01)

Strong inflammatory signatures in the neutrophils of PAMI syndrome
by: Wenjie Zheng, et al.
Published: (2022-09-01)